Contrast Media Market Trends
Contrast Media Market Research Report Information By Type (Iodinated Contrast Media, Gadolinium-Based Contrast Media), By Form (Tablet, Powder, Liquid, Paste), By Procedures (X-ray/Computed Tomography, Magnetic Resonance Imaging), By Application (Cardiovascular Disease, Oncology, Gastrointestinal Disorders), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market For...

Market Summary
As per Market Research Future Analysis, the Global Contrast Media Market was valued at USD 6.36 Billion in 2023 and is projected to grow to USD 18.23 Billion by 2032, with a CAGR of 4.76% from 2024 to 2032. The market is driven by the increasing number of diagnostic procedures and the rising popularity of minimally invasive treatments. Iodinated contrast agents dominate the market due to their extensive use in X-ray and CT imaging, enhancing visualization of various internal organs. The demand for innovative imaging solutions and image-guided procedures is further propelling market growth.
Key Market Trends & Highlights
The Contrast Media Market is witnessing significant growth driven by advancements in diagnostic imaging and increasing healthcare needs.
- Market Size in 2023: USD 6.36 Billion; projected to reach USD 18.23 Billion by 2032.
- CAGR of 4.76% during the forecast period (2024-2032).
- Iodinated contrast agents accounted for the largest market share in 2022.
- North America held a market share of USD 1.4 Billion in 2022.
Market Size & Forecast
2023 Market Size | USD 6.36 Billion |
2032 Market Size | USD 18.23 Billion |
CAGR | 4.76% |
Largest Regional Market Share in 2022 | North America. |
Major Players
Key players include Bayer AG, Bracco Diagnostic Inc, GE Healthcare, Guerbet Group, and Lantheus Medical Imaging Inc.
Market Trends
Growing Demand for Diagnostics Imaging to boost the market growth
Chronic diseases of many types are prevalent ly, and the demand for diagnostic imaging is at an all-time high. Imaging services per Medicare beneficiary saw the highest increase in the number of imaging services per Medicare beneficiary of all other services provided by physicians, according to a report from the Medicare Payment Advisory Council (MedPAC) to the Centers for Medicare and Medicaid Services (CMS).
Image-guided surgery (IGS) is gaining acceptance over time. These procedures are useful in diagnosing and treating a variety of conditions. The growing demand for imaging refinement during surgery requires unique data acquisition, processing, display methods, and a comprehensive understanding of the imaging process and its application in therapy. Image-guided procedures are well addressing this need, which has led to an increase in demand for diagnosis and treatment, thus acting as a factor is further enhanced the market CAGR of contrast media across the globe in recent years.
Healthcare professionals and people worldwide are increasingly embracing minimally invasive therapies and image-guided procedures. Ultrasonography has undergone a considerable transformation from traditional diagnostic imaging in obstetrics and gynecology to treating kidney stones, malignancies, and other clinical conditions. These initiatives will likely create new opportunities for manufacturers in the market of contrast media to increase revenue. The market for contrast media has the potential to become more attractive owing to the increasing public demand for diagnostic imaging services and the increasing availability of various diagnostic imaging modalities.
Moreover, marketing companies in the contrast media market are launching new cutting-edge technologies and high-quality products with cutting-edge features.
The increasing use of medical imaging is increasing the market demand for the contrast media and enhancing the market growth of the Contrast Media.
The increasing prevalence of chronic diseases and the growing demand for advanced imaging techniques are driving the expansion of the global contrast media market, reflecting a critical evolution in diagnostic capabilities.
U.S. Food and Drug Administration (FDA)
Contrast Media Market Market Drivers
Rising Demand for Diagnostic Imaging
The Global Contrast Media Market Industry experiences a notable surge in demand for diagnostic imaging procedures, driven by the increasing prevalence of chronic diseases and the aging population. As healthcare systems globally prioritize early diagnosis and treatment, the utilization of contrast media in imaging techniques such as MRI and CT scans becomes essential. In 2024, the market is projected to reach 6.74 USD Billion, reflecting the growing reliance on advanced imaging technologies. This trend is expected to continue, with the market potentially expanding to 21.0 USD Billion by 2035, indicating a robust CAGR of 10.86% from 2025 to 2035.
Market Segment Insights
Contrast Media Type Insights
In the Contrast Media market segmentation, based on type, iodinated contrast media, gadolinium-based contrast media. The iodinated contrast agents segment accounted for the largest market share in 2022, which can be attributed to the high penetration rate of X-ray and C.T. procedures and the availability of non-ionically stable iodinated agents for improved diagnosis. Iodine-containing contrast agents are usually given intravenously; however, in some cases, they are replaced by barium-based contrast agents for oral and rectal administration. Iodine-based contrast agents are used to enhancing C.T. and X-ray images.
They enhance visualization of the gastrointestinal tract, internal organs, arteries and veins, soft tissues, and the brain. Iodinated contrast agents are used in various indications, including neurological, renal, gastrointestinal, cardiovascular and musculoskeletal disorders and cancer. Thus, the contrast media market revenue is increasing.
Figure 2: Contrast Media Market, by Type, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
Contrast Media Form Insights
The Contrast Media market segmentation, The market has been segmented based on form into liquid, tablet, powder, and paste. The target audience prefers all these forms according to the requirements of the product.
Contrast Media Procedures Insights
The Contrast Media market data, based on procedures, X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI). Among these, the X-ray/C.T. contrast agents help generate high-resolution 3D images of structures. Barium-based and iodinated contrast agents are used in X-ray and C.T. techniques. When barium and iodine contrast agents are administered/injected into the body, they block X-rays and don't allow them to pass through. As a result, organs, blood vessels, and other body tissues that temporarily contain barium-based or iodinated contrast media change in appearance. X-ray and C.T. are widely used in several diseases and are expected to stimulate market growth.
Contrast Media Application Insights
The application-based market data of contrast media includes cardiovascular disease, oncology, and gastrointestinal disorders. The fertilizer category holds the major market share. The cardiovascular diseases (CVD) segment is expected to account for a large revenue share during the forecast period. This is due to the increasing prevalence of cardiovascular diseases worldwide. According to the National Center for Biotechnology Information (NCBI), the disease is expected to affect 6 to 12 Billion people worldwide by 2050 and 17.9 Billion in Europe by 2060. Moreover, the increasing prevalence of cardiovascular diseases generates a huge demand for innovations in the contrast media industry.
News
April 2023, Japanese researchers investigated if switching the ICM that initially triggered an adverse reaction in a patient to a different agent could lessen the chance of a further adverse reaction. Data analysis showed that patients who had experienced an ICM-induced hypersensitive reaction before were 61% less likely to experience a repeat reaction if they switched ICMs. Independent efforts have been made to enhance reaction documentation at the Mayo Clinic and elsewhere. Adoption by other hospitals would be aided by standardizing this procedure.
According to a preliminary analysis that was carried out by the firm in June 2023, the magnetic resonance imaging (MRI) contrast agent SN132D that was developed by Spago NanoMedical was shown to be well tolerated in patients who suffered from endometriosis. Spago Nanomedical claims that the drug has an excellent safety profile, despite the fact that further study of its MRI contrast-enhancing characteristics in lesions indicative of deep endometriosis is required.
Get more detailed insights about Contrast Media Market Research Report - Global Forecast till 2032
Regional Insights
By Region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North America Contrast Media market accounted for USD 1.4 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. Market growth is expected to accelerate due to various strategic initiatives by major manufacturers targeting niche patient subsets in this segment. Key players in the market include Bayer, GE Healthcare, Guerbet, Lantheus, and Bracco Diagnostics.
Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: CONTRAST MEDIA MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
The European contrast media market region is expected to take second place. The product demand in the region is growing owing to rising healthcare spending, the presence of more medical device companies in the region, and the growing market revenue in the region. Moreover, UK market of contrast media held the largest market share, and the Germany market of contrast media was the fastest-growing market in the European region.
The Asia Pacific contrast media market will also account for a large share in 2022. This can be attributed to well-established local and foreign manufacturers in the Region region. For example, G.E. Pharmaceuticals (Shanghai) Co., Ltd. is a branch of G.E. in China for diagnostic drugs (CT/MR contrast agents), and it is one of the largest production bases of G.E. Healthcare in the world for contrast agents. This factor is expected to continue to drive regional market growth.
Moreover, China market of contrast media held the largest market share, and the India market of contrast media was the fastest-growing market in the region.
Key Players and Competitive Insights
Major market players are investing heavily in research and development to increase their product lines, which will help the market of contrast media to grow further. The market players have also undertaken several strategic initiatives to expand their footprints, including key market developments such as new product launches, contractual agreements, mergers and acquisitions, increasing investments, and collaborations with other organizations. Competitors in the Contrast Media industry must offer cost-effective products to expand and survive in the increasingly competitive and rising market environment.
One of the key business strategies adopted by the manufacturers in the Contrast Media agents industry to benefit their customers and expand their market segment is to manufacture locally to reduce operating costs. In recent years, the Contrast Media industry has provided some of the most significant benefits to medicine. Major players in the market of Contrast Media, such as Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E.
Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.) are focusing on expanding the market demand by investing in research and development activities.
Beijing Beilu Pharmaceutical Co., Ltd. is engaged in the research and development, production and sales of pharmaceutical products. The company's products include Iopamidol Injection, Iodixanol Injection, Repaglinide Tablets and other contrast agent series, and psychiatric and hypoglycemic products. In February 2022, Hokuri Pharmaceutical's loperamide passed the consistency evaluation of generic drugs. The assessment helps to review the quality and efficacy of generic drugs compared to brand-name drugs.
Also, Bayer AG is a German multinational pharmaceutical and biotechnology company and one of the largest pharmaceutical companies in the world. Headquartered in Leverkusen, Bayer's business areas include pharmaceuticals, consumer healthcare, agrochemicals, seeds and biotechnology products. In July 2020, Bayer and Siemens Healthineers presented a new imaging system interface (ISI) for magnetic resonance imaging. The interface combines Bayer's MRXperion MR injection system with a Siemens Healthineers MR scanner to overcome challenges faced by traditional methods.
Key Companies in the Contrast Media Market market include



Industry Developments
October 2022: G.E. Healthcare's pharmaceutical diagnostics company announced a long-term agreement with the Chilean mining company Sociedad Quimica y Minera (SQM) de Chile S.A. to guarantee its supply of iodine, which is used in X-ray contrast media products. Vital components and computed tomography procedures around the world. As part of G.E. Healthcare's larger commitment and investment plan, this will help SQM expand its supply of iodine raw material year-on-year, producing an additional 30 Billion doses of iodine contrast media per year by 2025.
December 2021: The previously announced G.E. Healthcare acquisition of B.K. Medical was finalized. With this acquisition, G.E. Healthcare has enhanced its pre- and post-operative ultrasound capabilities to cover real-time surgical observation, a fast-growing and relatively new discipline.
Future Outlook
Contrast Media Market Future Outlook
The Global Contrast Media Market is projected to grow at a 10.86% CAGR from 2024 to 2035, driven by technological advancements, increasing diagnostic imaging demand, and rising healthcare expenditures.
New opportunities lie in:
- Develop novel contrast agents for specific imaging modalities to enhance diagnostic accuracy.
- Leverage AI and machine learning for personalized imaging solutions and improved patient outcomes.
- Expand distribution networks in emerging markets to capture growing healthcare investments.
By 2035, the Global Contrast Media Market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological innovations.
Market Segmentation
Contrast Media Form Outlook
- Tablet
- Powder
- Liquid
- Paste
Contrast Media Type Outlook
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
Contrast Media Regional Outlook
- US
- Canada
Contrast Media Procedure Outlook
- X-ray/Computed Tomography (C.T.)
- Magnetic Resonance Imaging (MRI)
- Swine
Contrast Media Application Outlook
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
Report Scope
Attribute/Metric | Details |
Market Size 2023 | USD 6.36 billion |
Market Size 2024 | USD 6.74 billion |
Market Size 2032 | USD 18.23 billion |
Compound Annual Growth Rate (CAGR) | 4.76% (2024-2032) |
Base Year | 2023 |
Market Forecast Period | 2024-2032 |
Historical Data | 2018 & 2021 |
Market Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Form, Procedures, Application, and Region |
Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
Countries Covered | The U.S, Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled | Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E. Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.) |
Key Market Opportunities | Increasing research on contrast agents. |
Key Market Dynamics | Growing prevalence of chronic diseases. The rising popularity of minimally invasive procedures. |
Market Highlights
Author
Latest Comments
This is a great article! Really helped me understand the topic better.
Thanks for sharing this. I’ve bookmarked it for later reference.
FAQs
What is the market size for contrast media?
The contrast media market size was valued at USD 6.36 billion in 2023 and is projected to grow from USD 6.74 Billion in 2024 to USD 18.23 billion by 2032
Which factors drives the contrast media market?
Growing Demand for Diagnostics Imaging drives the global contrast media market
What are the types of contrast media?
Iodinated Contrast Media, Gadolinium-Based Contrast Media are the types of contrast media
Which region is expected to dominate the contrast media market?
North America is expected to dominate the global contrast media market
Who makes contrast media?
Major players in the market of Contrast Media, such as Bayer AG (Germany), Bracco Diagnostic Inc (U.S.), DAIICHI (Japan), NANOSCAN IMAGING (U.S.), Jodas Expoim (India), G.E. Healthcare (U.S.), Guerbet Group (France), Lantheus Medical Imaging Inc (U.S.), Taejoon Pharm (Korea), Magnus Health (U.S.)
-
'Table of Contents
- Definition
-
Scope of the Study
- Research Objective
- Assumptions
- Limitations
- Overview
- Primary Research
- Secondary Research
- Market Size Estimation
- Overview
- Drivers
- Restraints
- Opportunities
- Porter’s Five Forces Analysis
-
Bargaining Power of Suppliers
-
Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Value Chain Analysis
- Overview
- Iodinated Contrast Media Market Estimates
-
Bargaining Power of Buyers
-
Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Gadolinium-based Contrast Media Market
-
Estimates & Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Microbubble Contrast Media Market
-
Estimates & Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Barium-based Contrast Media Market
-
Estimates & Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Overview
- Market
-
Estimates & Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Powder Market Estimates
-
Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Liquid
-
Market Estimates & Forecast, by Region, 2022-2030 Market
-
Estimates & Forecast, by Country, 2022-2030
- Paste
-
Market Estimates & Forecast, by Region, 2022-2030 Market Estimates
-
Forecast, by Country, 2022-2030
- Overview
- X-Ray/Computed Tomography (CT)
-
Market Estimates & Forecast, by Region, 2022-2030 Market
-
Estimates & Forecast, by Country, 2022-2030
- Magnetic Resonance Imaging (MRI)
-
Market Estimates & Forecast, by Region, 2022-2030 Market
-
Estimates & Forecast, by Country, 2022-2030
- Ultrasound
-
Market Estimates & Forecast, by Region, 2022-2030 Market Estimates
-
Forecast, by Country, 2022-2030
- Overview
- Cardiovascular Disease
-
Market Estimates & Forecast, by Region, 2022-2030 Market Estimates
-
Forecast, by Country, 2022-2030
- Oncology
-
Market Estimates & Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Gastrointestinal Disorders
-
Market Estimates & Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Neurological Disorders Market
-
Estimates & Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Other Indications Market Estimates
-
Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
-
BY ROUTE OF ADMINISTRATION
- Overview
- Rectal
-
Market Estimates & Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Oral Market
-
Estimates & Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Injectable Market Estimates
-
Forecast, by Region, 2022-2030
-
Market Estimates & Forecast, by Country, 2022-2030
- Overview
-
Americas
- North America
- Latin America
-
Europe
- Western Europe
-
Rest of Western Europe
- Eastern Europe
-
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
-
Middle East & Africa
-
Middle East
- Africa
- Overview
- Competitive Analysis
- Market Share Analysis
- Major Growth Strategy in the Global Contrast Media Market
- Competitive Benchmarking
- Leading Players in terms of Number of Developments in the Global Contrast Media Market
-
Middle East
-
Key developments and Growth Strategies
-
New Product Launch/Service Deployment
- Merger & acquisitions
- Joint Ventures
-
New Product Launch/Service Deployment
-
Major Players Financial Matrix & Market Ratio
-
Sales & Operating Income 2020
- Major Players R&D Expenditure 2020
- Major Players Capital Market Ratio
-
DAIICHI
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
- Key Strategies
-
NANOSCAN IMAGING
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
- Key Strategies
-
Bayer AG
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
- Key Strategies
-
Bracco Diagnostic Inc
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
- Key Strategies
-
GE Healthcare
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
- Key Strategies
-
Guerbet Group
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
- Key Strategies
-
Jodas Expoim
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
- Key Strategies
-
Lantheus Medical Imaging Inc.
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
- Key Strategies
-
Magnus Health
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
- Key Strategies
-
Spago Nanomedical AB
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
- Key Strategies
-
Taejoon Pharm
- Company Overview
- Product Overview
- Financial Overview
- Key Developments
- SWOT Analysis
- Key Strategies
- Others
- References
- Related Reports LIST OF TABLES
-
Sales & Operating Income 2020
-
FORECAST, 2022-2030 (USD MILLION) MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION)
-
2022-2030 (USD MILLION) MILLION)
-
MEDIA MARKET, BY REGION, 2022-2030 (USD MILLION)
-
2022-2030 (USD MILLION) MILLION)
-
CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION) MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION) BY TYPE, 2022-2030 (USD MILLION) MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION)
-
2022-2030 (USD MILLION) (USD MILLION)
-
MARKET, BY FORM, 2022-2030 (USD MILLION) (USD MILLION)
-
MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION) MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION) FORM, 2022-2030 (USD MILLION) (USD MILLION)
-
CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION) MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION)
-
2022-2030 (USD MILLION) MILLION)
-
MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION) MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION) FORM, 2022-2030 (USD MILLION) (USD MILLION)
-
CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION) CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION) FORM, 2022-2030 (USD MILLION) (USD MILLION)
-
CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION) CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION) FORM, 2022-2030 (USD MILLION) (USD MILLION)
-
CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION) & AFRICA: CONTRAST MEDIA MARKET, BY TYPE, 2022-2030 (USD MILLION) & AFRICA: CONTRAST MEDIA MARKET, BY FORM, 2022-2030 (USD MILLION) & AFRICA: CONTRAST MEDIA MARKET, BY PROCEDURES, 2022-2030 (USD MILLION) & AFRICA: CONTRAST MEDIA MARKET, BY APPLICATION, 2022-2030 (USD MILLION) & AFRICA: CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD MILLION) PROCESS
-
2020 (%)
-
MARKET SHARE, BY APPLICATION, 2020 (%) ADMINISTRATION, 2020 (%) MEDIA MARKET SHARE, BY REGION, 2020 (%) COUNTRY, 2020 (%)
-
BY COUNTRY, 2020 (%)
-
CONTRAST MEDIA MARKET SHARE, BY COUNTRY, 2020 (%) ANALYSIS, 2020 (%)
Contrast Media Market Segmentation
Contrast Media Market Type Outlook (USD Billion, 2018-2030)
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
Contrast Media Market Form Outlook (USD Billion, 2018-2030)
- Tablet
- Powder
- Liquid
- Paste
Contrast Media Market Procedure Outlook (USD Billion, 2018-2030)
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
Contrast Media Market Application Outlook (USD Billion, 2018-2030)
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
Contrast Media Market Regional Outlook (USD Billion, 2018-2030)
- North America Outlook (USD Billion, 2018-2030)
- North America Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- North America Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- North America Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- North America Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- US Outlook (USD Billion, 2018-2030)
- US Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- US Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- US Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- US Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- CANADA Outlook (USD Billion, 2018-2030)
- CANADA Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- CANADA Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- CANADA Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- CANADA Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Europe Outlook (USD Billion, 2018-2030)
- Europe Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Europe Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- Europe Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Europe Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Germany Outlook (USD Billion, 2018-2030)
- Germany Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Germany Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- Germany Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Germany Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- France Outlook (USD Billion, 2018-2030)
- France Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- France Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- France Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- France Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- UK Outlook (USD Billion, 2018-2030)
- UK Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- UK Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- UK Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- UK Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- ITALY Outlook (USD Billion, 2018-2030)
- ITALY Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- ITALY Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- ITALY Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- ITALY Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- SPAIN Outlook (USD Billion, 2018-2030)
- Spain Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Spain Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- Spain Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Spain Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Rest Of Europe Outlook (USD Billion, 2018-2030)
- Rest Of Europe Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- REST OF EUROPE Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- REST OF EUROPE Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- REST OF EUROPE Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Asia-Pacific Outlook (USD Billion, 2018-2030)
- Asia-Pacific Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Asia-Pacific Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- Asia-Pacific Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Asia-Pacific Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- China Outlook (USD Billion, 2018-2030)
- China Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- China Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- China Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- China Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Japan Outlook (USD Billion, 2018-2030)
- Japan Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Japan Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- Japan Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Japan Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- India Outlook (USD Billion, 2018-2030)
- India Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- India Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- India Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- India Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Australia Outlook (USD Billion, 2018-2030)
- Australia Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Australia Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- Australia Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Australia Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)
- Rest of Asia-Pacific Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Rest of Asia-Pacific Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- Rest of Asia-Pacific Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Rest of Asia Pacific Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Rest of the World Outlook (USD Billion, 2018-2030)
- Rest of the World Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Rest of the World Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- Rest of the World Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Rest of the World Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Middle East Outlook (USD Billion, 2018-2030)
- Middle East Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Middle East Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- Middle East Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Middle East Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Africa Outlook (USD Billion, 2018-2030)
- Africa Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Africa Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- Africa Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Africa Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Latin America Outlook (USD Billion, 2018-2030)
- Latin America Contrast Media Market by Type
- Iodinated Contrast Media
- Gadolinium-Based Contrast Media
- Latin America Contrast Media Market by Form
- Tablet
- Powder
- Liquid
- Paste
- Latin America Contrast Media Market by Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Latin America Contrast Media Market by Application
- Cardiovascular Disease
- Oncology
- Gastrointestinal Disorders
- Rest of the World Contrast Media Market by Type
- Asia-Pacific Contrast Media Market by Type
- Europe Contrast Media Market by Type
- North America Contrast Media Market by Type

Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment